Cargando…

Hepatitis viruses in Ethiopia: a systematic review and meta-analysis

BACKGROUND: The existing seroepidemiological data on viral hepatitis in Ethiopia showed a wide variation in prevalence pattern and the clinical and public health burden have been underestimated. The aim of this systematic review and meta-analysis was to provide a clear and comprehensive estimation o...

Descripción completa

Detalles Bibliográficos
Autores principales: Belyhun, Yeshambel, Maier, Melanie, Mulu, Andargachew, Diro, Ermias, Liebert, Uwe Gerd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5168848/
https://www.ncbi.nlm.nih.gov/pubmed/27993129
http://dx.doi.org/10.1186/s12879-016-2090-1
_version_ 1782483424737492992
author Belyhun, Yeshambel
Maier, Melanie
Mulu, Andargachew
Diro, Ermias
Liebert, Uwe Gerd
author_facet Belyhun, Yeshambel
Maier, Melanie
Mulu, Andargachew
Diro, Ermias
Liebert, Uwe Gerd
author_sort Belyhun, Yeshambel
collection PubMed
description BACKGROUND: The existing seroepidemiological data on viral hepatitis in Ethiopia showed a wide variation in prevalence pattern and the clinical and public health burden have been underestimated. The aim of this systematic review and meta-analysis was to provide a clear and comprehensive estimation of viral hepatitis epidemiology and the potential clinical burdens in Ethiopia. METHODS: A comprehensive literature search was carried out from five decades (1968–2015) published studies from biomedical databases; PubMed, Google scholar, Medline and Web of Science. RESULTS: The overall pooled prevalence of hepatitis B virus (HBV) was 7.4% (95%CI: 6.5–8.4). The pooled prevalence among subgroups showed 5.2% (95%CI: 3.7–7.4) in human immunodeficiency virus (HIV) infected individuals, 8.0% (95%CI: 5.9–10.7) in community based studies, 8.4% (95%CI: 5.4–12.7) in blood donors, 11.0% (95%CI: 7.5–15.9) in immigrants and 6.9% (95%CI: 5.6–8.5) in other groups. Among study parameters considered during meta-regression analysis, only study years were associated with a decreasing HBV prevalence rate over time. The overall pooled prevalence of anti-hepatitis C virus antibody (anti-HCV) was 3.1% (95%CI: 2.2–4.4). Unlike HBV, the anti-HCV prevalence in HIV infected individuals was higher (5.5%, 95%CI: 3.8–7.8%, p = 0.01) than the prevalence observed in the other subgroup of study population. Although relatively few data were available, hepatitis virus A (HAV), D (HDV) and E (HEV) were also circulated in Ethiopia. CONCLUSIONS: This review indicates that all types of viral hepatitis origins are endemic in Ethiopia. Adapting a recommended diagnostic and treatment algorithm of viral hepatitis in the routine healthcare systems and implementing prevention and control policies in the general population needs an urgent attention. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12879-016-2090-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5168848
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-51688482016-12-28 Hepatitis viruses in Ethiopia: a systematic review and meta-analysis Belyhun, Yeshambel Maier, Melanie Mulu, Andargachew Diro, Ermias Liebert, Uwe Gerd BMC Infect Dis Research Article BACKGROUND: The existing seroepidemiological data on viral hepatitis in Ethiopia showed a wide variation in prevalence pattern and the clinical and public health burden have been underestimated. The aim of this systematic review and meta-analysis was to provide a clear and comprehensive estimation of viral hepatitis epidemiology and the potential clinical burdens in Ethiopia. METHODS: A comprehensive literature search was carried out from five decades (1968–2015) published studies from biomedical databases; PubMed, Google scholar, Medline and Web of Science. RESULTS: The overall pooled prevalence of hepatitis B virus (HBV) was 7.4% (95%CI: 6.5–8.4). The pooled prevalence among subgroups showed 5.2% (95%CI: 3.7–7.4) in human immunodeficiency virus (HIV) infected individuals, 8.0% (95%CI: 5.9–10.7) in community based studies, 8.4% (95%CI: 5.4–12.7) in blood donors, 11.0% (95%CI: 7.5–15.9) in immigrants and 6.9% (95%CI: 5.6–8.5) in other groups. Among study parameters considered during meta-regression analysis, only study years were associated with a decreasing HBV prevalence rate over time. The overall pooled prevalence of anti-hepatitis C virus antibody (anti-HCV) was 3.1% (95%CI: 2.2–4.4). Unlike HBV, the anti-HCV prevalence in HIV infected individuals was higher (5.5%, 95%CI: 3.8–7.8%, p = 0.01) than the prevalence observed in the other subgroup of study population. Although relatively few data were available, hepatitis virus A (HAV), D (HDV) and E (HEV) were also circulated in Ethiopia. CONCLUSIONS: This review indicates that all types of viral hepatitis origins are endemic in Ethiopia. Adapting a recommended diagnostic and treatment algorithm of viral hepatitis in the routine healthcare systems and implementing prevention and control policies in the general population needs an urgent attention. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12879-016-2090-1) contains supplementary material, which is available to authorized users. BioMed Central 2016-12-19 /pmc/articles/PMC5168848/ /pubmed/27993129 http://dx.doi.org/10.1186/s12879-016-2090-1 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Belyhun, Yeshambel
Maier, Melanie
Mulu, Andargachew
Diro, Ermias
Liebert, Uwe Gerd
Hepatitis viruses in Ethiopia: a systematic review and meta-analysis
title Hepatitis viruses in Ethiopia: a systematic review and meta-analysis
title_full Hepatitis viruses in Ethiopia: a systematic review and meta-analysis
title_fullStr Hepatitis viruses in Ethiopia: a systematic review and meta-analysis
title_full_unstemmed Hepatitis viruses in Ethiopia: a systematic review and meta-analysis
title_short Hepatitis viruses in Ethiopia: a systematic review and meta-analysis
title_sort hepatitis viruses in ethiopia: a systematic review and meta-analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5168848/
https://www.ncbi.nlm.nih.gov/pubmed/27993129
http://dx.doi.org/10.1186/s12879-016-2090-1
work_keys_str_mv AT belyhunyeshambel hepatitisvirusesinethiopiaasystematicreviewandmetaanalysis
AT maiermelanie hepatitisvirusesinethiopiaasystematicreviewandmetaanalysis
AT muluandargachew hepatitisvirusesinethiopiaasystematicreviewandmetaanalysis
AT diroermias hepatitisvirusesinethiopiaasystematicreviewandmetaanalysis
AT liebertuwegerd hepatitisvirusesinethiopiaasystematicreviewandmetaanalysis